Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Phase I Multi-Dose Escalation Study of the Anti-CD19 Maytansinoid Immunoconjugate SAR3419 Administered by Intravenous (IV) Infusion Every 3 Weeks to Patients with Relapsed/ Refractory B-Cell Non-Hodgkin's Lymphoma (NHL).

Anas Younes, MD, Leo Gordon, MD, Stella Kim, MD, Jorge Romaguera, MD, Amanda R Copeland, MS, Silvana de Castro Farial, MD, Larry Kwak, MD, PHD, Luis Fayad, MD, Frederick Hagemeister, MD, Michelle Fanale, M.D., John Lambert, PhD, Teresa Bagulho, MD, Rodica Morariu-Zamfir, MD

Blood (2009) 114 (22): 585.

https://doi.org/10.1182/blood.V114.22.585.585

Published: 2009

Journal Articles

Tacrolimus Dosing in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients Receiving Concomitant Voriconazole.

Steven Trifilio, Judy Pi, Seema Singhal, Olga Frankfurt, Andrew Evens, Leo Gordon, Martin Tallman, Jane Winter, Stephanie Williams, Jayesh Mehta

Blood (2007) 110 (11): 4956.

https://doi.org/10.1182/blood.V110.11.4956.4956

Published: 2007

Journal Articles

Outcome of Relapse after Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) - The Effect of the Underlying Disease on Survival Following Relapse.

Seema Singhal, Olga Frankfurt, Andrew Evens, Leo Gordon, Martin Tallman, Stephanie Williams, Jane Winter, David Grinblatt, Lynne Kaminer, Jayesh Mehta

Blood (2007) 110 (11): 5020.

https://doi.org/10.1182/blood.V110.11.5020.5020

Published: 2007

Journal Articles

Submyeloablative Allografts for Hematologic Malignancies: Validation of a Prognostic Model Based on Pre-Transplant Variables.

Jayesh Mehta, Jane Winter, Martin Tallman, Leo Gordon, Stephanie Williams, Olga Frankfurt, Andrew Evens, David Grinblatt, Lynne Kaminer, Richard Meagher, Seema Singhal

Blood (2006) 108 (11): 3036.

https://doi.org/10.1182/blood.V108.11.3036.3036

Published: 2006

Journal Articles

Reduced-Intesity Allogeneic HSCT in Hematologic Malignancies: Influence of Underlying Diagnosis and Prior Autograft on Outcome.

Jayesh Mehta, Leo Gordon, Martin Tallman, Jane Winter, Stephanie Williams, Olga Frankfurt, Andrew Evens, David Grinblatt, Lynne Kaminer, Richard Meagher, Kamran Rashid, Donna Grabowski, Seema Singhal

Blood (2006) 108 (11): 3040.

https://doi.org/10.1182/blood.V108.11.3040.3040

Published: 2006

Journal Articles

Breakthrough Fungal Infections after Allogeneic Hematopoietic Stem Cell Transplantation in Patients on Prophylactic Voriconazole.

Steve Trifilio, Seema Singhal, Stephanie Williams, Jane Winter, Martin Tallman, Leo Gordon, Olga Frankfurt, Andrew Evens, Jayesh Mehta

Blood (2006) 108 (11): 2849.

https://doi.org/10.1182/blood.V108.11.2849.2849

Published: 2006

Journal Articles

Submyeloablative Allogeneic HSCT for Hematologic Malignancies: Effect of Body Weight.

Seema Singhal, Leo Gordon, Martin Tallman, Jane Winter, Stephanie Williams, Olga Frankfurt, Andrew Evens, Richard Meagher, Lynne Kaminer, David Grinblatt, Jayesh Mehta

Blood (2006) 108 (11): 2949.

https://doi.org/10.1182/blood.V108.11.2949.2949

Published: 2006

Journal Articles

Comparison of Out-of-Pocket Costs for Patients (pts) with Hodgkin’s Disease (HD), Indolent Non-Hodgkin’s Lymphoma (INHL) and Aggressive Non-Hodgkin’s Lymphoma (ANHL).

Kathryn McCaffrey, BA, Matthew Fisher, Lucie Kutikova, PhD, Lee Bowman, PhD, Andrew Evens, DO, Leo Gordon, MD, Heather Auto, Charles Bennett, MD, PhD

Blood (2005) 106 (11): 2241.

https://doi.org/10.1182/blood.V106.11.2241.2241

Published: 2005

Journal Articles

Motexafin Gadolinium (MGd) Has Clinical Activity in Relapsed/Refractory Low Grade Lymphomas (LG) and Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL).

Brad S. Kahl, MD, Ranjana Advani, MD, Neil Kay, MD, Izidore S. Lossos, MD, Andrew Evens, DO, Leo Gordon, MD, Richard A. Miller, MD, See-Chun Phan, MD

Blood (2005) 106 (11): 4758.

https://doi.org/10.1182/blood.V106.11.4758.4758

Published: 2005

Journal Articles

Rituximab, Bevacizumab (Avastin) and CHOP (RA-CHOP) for Patients with Diffuse Large B-Cell Lymphoma (DLBCL).

Kristen N. Ganjoo, MD, Leo Gordon, MD, Michael J. Robertson, MD, Sandra J. Horning, MD

Blood (2004) 104 (11): 1384.

https://doi.org/10.1182/blood.V104.11.1384.1384

Published: 2004

NARROW

Phase I Multi-Dose Escalation Study of the Anti-CD19 Maytansinoid Immunoconjugate SAR3419 Administered by Intravenous (IV) Infusion Every 3 Weeks to Patients with Relapsed/ Refractory B-Cell Non-Hodgkin's Lymphoma (NHL).

Tacrolimus Dosing in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients Receiving Concomitant Voriconazole.

Outcome of Relapse after Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) - The Effect of the Underlying Disease on Survival Following Relapse.

Submyeloablative Allografts for Hematologic Malignancies: Validation of a Prognostic Model Based on Pre-Transplant Variables.

Reduced-Intesity Allogeneic HSCT in Hematologic Malignancies: Influence of Underlying Diagnosis and Prior Autograft on Outcome.

Breakthrough Fungal Infections after Allogeneic Hematopoietic Stem Cell Transplantation in Patients on Prophylactic Voriconazole.

Submyeloablative Allogeneic HSCT for Hematologic Malignancies: Effect of Body Weight.

Comparison of Out-of-Pocket Costs for Patients (pts) with Hodgkin’s Disease (HD), Indolent Non-Hodgkin’s Lymphoma (INHL) and Aggressive Non-Hodgkin’s Lymphoma (ANHL).

Motexafin Gadolinium (MGd) Has Clinical Activity in Relapsed/Refractory Low Grade Lymphomas (LG) and Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL).

Rituximab, Bevacizumab (Avastin) and CHOP (RA-CHOP) for Patients with Diffuse Large B-Cell Lymphoma (DLBCL).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only